Strides Pharma Science Limited

Strides Pharma Science Limited (STAR) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

strides.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹1047.80
Market cap
9,660 Cr
Stock P/E
13.6
P/B
3.07
Dividend yield
0.4%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023BSE balance sheet (this exchange's own filing had none for this period)Mar 2024Jun 2024BSE balance sheet (this exchange's own filing had none for this period)Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales999 Cr1,038 Cr1,084 Cr1,088 Cr1,201 Cr1,154 Cr1,190 Cr1,120 Cr1,221 Cr1,195 Cr1,323 Cr1,265 Cr
Operating expenses (approx.)846 Cr844 Cr854 Cr871 Cr965 Cr943 Cr973 Cr902 Cr989 Cr959 Cr1,084 Cr1,036 Cr
EBITDA153 Cr194 Cr230 Cr217 Cr236 Cr210 Cr218 Cr218 Cr232 Cr236 Cr240 Cr230 Cr
OPM %15.3%18.7%21.2%20.0%19.6%18.2%18.3%19.5%19.0%19.8%18.1%18.2%
Other income36 Cr9 Cr-14 Cr13 Cr28 Cr6 Cr12 Cr9 Cr27 Cr107 Cr8 Cr5 Cr
Interest79 Cr79 Cr80 Cr80 Cr82 Cr52 Cr50 Cr47 Cr46 Cr43 Cr42 Cr41 Cr
Depreciation60 Cr51 Cr50 Cr49 Cr51 Cr48 Cr49 Cr49 Cr50 Cr51 Cr53 Cr56 Cr
Profit before tax-157 Cr64 Cr30 Cr85 Cr115 Cr114 Cr106 Cr122 Cr153 Cr245 Cr148 Cr200 Cr
Tax %4.7%15.7%64.8%19.8%18.5%20.9%19.5%13.5%14.1%15.2%12.7%17.1%
Net profit-149 Cr54 Cr10 Cr68 Cr94 Cr90 Cr86 Cr106 Cr132 Cr208 Cr129 Cr165 Cr
EPS (₹)₹-14.54₹5.43₹1.98₹7.64₹10.14₹9.56₹8.92₹10.81₹13.84₹21.93₹13.77₹17.02

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3,012 Cr2,752 Cr3,316 Cr3,070 Cr3,688 Cr4,051 Cr4,565 Cr4,859 CrSign in for TTM
Operating expenses (approx.)2,557 Cr2,236 Cr2,681 Cr3,090 Cr3,258 Cr3,308 Cr3,763 Cr3,933 CrSign in for TTM
EBITDA455 Cr516 Cr635 Cr-20 Cr430 Cr743 Cr803 Cr925 CrSign in for TTM
OPM %15.1%18.7%19.1%-0.7%11.7%18.3%17.6%19.0%Sign in for TTM
Other income45 Cr53 Cr51 Cr132 Cr90 Cr40 Cr59 Cr151 CrSign in for TTM
Interest205 Cr156 Cr150 Cr177 Cr261 Cr314 Cr249 Cr179 CrSign in for TTM
Depreciation172 Cr174 Cr206 Cr233 Cr243 Cr221 Cr192 Cr202 CrSign in for TTM
Profit before tax393 Cr156 Cr289 Cr-653 Cr-268 Cr-63 Cr3,675 Cr669 CrSign in for TTM
Tax %3.3%7.3%10.9%27.3%20.7%-50.4%2.1%14.1%Sign in for TTM
Net profit330 Cr31 Cr258 Cr-474 Cr-212 Cr-94 Cr3,598 Cr575 CrSign in for TTM
EPS (₹)₹36.25₹4.06₹29.96₹-51.28₹-22.49₹-7.76₹390.54₹60.34Sign in for TTM
Dividend payout %——————0.6%6.4%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital90 Cr90 Cr90 Cr90 Cr90 Cr92 Cr92 Cr92 Cr
Reserves2,559 Cr2,438 Cr2,687 Cr2,269 Cr2,122 Cr2,034 Cr2,460 Cr3,015 Cr
Borrowings3,146 Cr1,833 Cr——2,774 Cr2,415 Cr1,796 Cr1,669 Cr
Other liabilities2,058 Cr1,724 Cr4,238 Cr4,617 Cr1,691 Cr1,354 Cr1,667 Cr2,109 Cr
Total liabilities8,006 Cr6,152 Cr7,015 Cr6,976 Cr6,638 Cr5,840 Cr6,049 Cr6,927 Cr
Fixed assets (net)1,037 Cr1,316 Cr——1,324 Cr879 Cr881 Cr992 Cr
CWIP102 Cr148 Cr——48 Cr80 Cr100 Cr161 Cr
Investments779 Cr622 Cr——502 Cr315 Cr420 Cr292 Cr
Loans & advances54 Cr15 Cr——8 Cr13 Cr10 Cr8 Cr
Inventories871 Cr783 Cr——1,147 Cr1,126 Cr1,278 Cr1,635 Cr
Trade receivables987 Cr932 Cr——1,299 Cr1,142 Cr1,203 Cr1,289 Cr
Cash & bank366 Cr182 Cr——304 Cr161 Cr113 Cr189 Cr
Other assets3,809 Cr2,154 Cr7,015 Cr6,976 Cr2,006 Cr2,125 Cr2,044 Cr2,361 Cr
Total assets8,006 Cr6,152 Cr7,015 Cr6,976 Cr6,638 Cr5,840 Cr6,049 Cr6,927 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———-258 Cr44 Cr701 Cr684 Cr703 Cr
Cash from investing———-119 Cr302 Cr-150 Cr-90 Cr-173 Cr
Cash from financing———421 Cr-214 Cr-693 Cr-643 Cr-453 Cr
Net cash flow———45 Cr133 Cr-142 Cr-48 Cr76 Cr
Free cash flow (OCF − Capex)———-401 Cr-51 Cr583 Cr442 Cr280 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %22.6%12.3%15.8%-20.2%-0.1%5.6%89.5%17.6%
ROE %12.3%1.4%9.7%-19.5%-9.3%-3.4%138.9%17.7%
Debtor days119124——1281039697
Inventory days316280——289307315382
Days payable325285——248232255306
Cash conversion cycle111118——170178156172
Debt / equity1.190.73——1.281.170.700.54
Current ratio1.130.93——1.051.031.201.25
Net debt / EBITDA0.000.000.00—5.743.032.101.60

Compare with peers

Loading peers…